Waters (WAT) said Tuesday its shareholders have approved the planned merger deal with Becton, Dickinson and Company's (BDX) Biosciences & Diagnostic Solutions business.
The firm said its stockholders approved the issuance of shares to shareholders of Becton, Dickinson and Company at a special meeting. The transaction is expected to close on Feb. 9.
Price: 388.97, Change: -1.94, Percent Change: -0.50